Clinical Trial: Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Evaluation of the Safety and Efficacy of Clopidogrel sulfate50mg and Clopidogrel Sulfate 75mg for the Treatment of Cerebral Infarction
Brief Summary: The primary objective is to compare the safety of clopidogrel 50mg and 75mg in cerebral infarction with respect to incidence of bleeding adverse events.
Detailed Summary:
Sponsor: Sanofi
Current Primary Outcome: Incidence of bleeding adverse events [ Time Frame: study period ]
Original Primary Outcome: Incidence of bleeding adverse events
Current Secondary Outcome: Incidence of Serious Adverse Events, serious bleeding events, adverse events. Incidence of vascular events. [ Time Frame: study period ]
Original Secondary Outcome: Incidence of Serious Adverse Events, serious bleeding events, adverse events. Incidence of vascular events.
Information By: Sanofi
Dates:
Date Received: October 10, 2006
Date Started: September 2006
Date Completion:
Last Updated: February 23, 2010
Last Verified: February 2010